Skip to main content

. 1946 Jul;25(4):534–540. doi: 10.1172/JCI101735

CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VIII. THE EFFECT OF BAL ON THE EXCRETION OF ARSENIC IN ARSENICAL INTOXICATION ^¹

John A Luetscher Jr ¹, Harry Eagle ¹, Warfield T Longcope ¹, Emily B Watson ¹

PMCID: PMC435591 PMID: 16695345

534

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Barron E. S., Singer T. P. ENZYME SYSTEMS CONTAINING ACTIVE SULFHYDRYL GROUPS. THE ROLE OF GLUTATHIONE. Science. 1943 Apr 16;97(2520):356–358. doi: 10.1126/science.97.2520.356. [DOI] [PubMed] [Google Scholar]
Longcope W. T., Luetscher J. A., Wintrobe M. M., Jäger V. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VII. THE TREATMENT OF ARSENICAL DERMATITIS WITH PREPARATIONS OF BAL. J Clin Invest. 1946 Jul;25(4):528–533. doi: 10.1172/JCI101734. [DOI] [PMC free article] [PubMed] [Google Scholar]
Public Health Weekly Reports for JANUARY 29, 1932. Public Health Rep. 1932 Jan 29;47(5):241–301. [PMC free article] [PubMed] [Google Scholar]
Walker E. Chemical constitution and toxicity. Biochem J. 1928;22(1):292–305. doi: 10.1042/bj0220292. [DOI] [PMC free article] [PubMed] [Google Scholar]
Waters L. L., Stock C. BAL (BRITISH ANTI-LEWISITE). Science. 1945 Dec 14;102(2659):601–606. doi: 10.1126/science.102.2659.601. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES